122 related articles for article (PubMed ID: 35970476)
1. Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.
Menguy S; Prochazkova-Carlotti M; Azzi-Martin L; Ferté T; Bresson-Bepoldin L; Rey C; Vergier B; Merlio JP; Beylot-Barry M; Pham-Ledard A
J Invest Dermatol; 2023 Jan; 143(1):124-133.e3. PubMed ID: 35970476
[TBL] [Abstract][Full Text] [Related]
2. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
3. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis.
Teichert M; Stumpf C; Booken N; Wobser M; Nashan D; Hallermann C; Mogler C; Müller CS; Becker JC; Moritz RK; Andrulis M; Nicolay JP; Goerdt S; Thomas M; Klemke CD; Augustin HG; Felcht M
Exp Dermatol; 2015 Jun; 24(6):424-9. PubMed ID: 25776770
[TBL] [Abstract][Full Text] [Related]
4. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences.
Felcht M; Klemke CD; Nicolay JP; Weiss C; Assaf C; Wobser M; Schlaak M; Hillen U; Moritz R; Tantcheva-Poor I; Nashan D; Beyer M; Dippel E; Müller CSL; Sachse MM; Meiss F; Géraud C; Marx A; Goerdt S; Geissinger E; Kempf W
J Dtsch Dermatol Ges; 2019 Mar; 17(3):275-285. PubMed ID: 30851152
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
[TBL] [Abstract][Full Text] [Related]
8. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
[TBL] [Abstract][Full Text] [Related]
12. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders.
Kamarashev J; Schaerer L; Burg G; Schmid MH; Müller B; Kempf W
J Cutan Pathol; 2001 Oct; 28(9):448-52. PubMed ID: 11553310
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
[TBL] [Abstract][Full Text] [Related]
15. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
[TBL] [Abstract][Full Text] [Related]
18. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment and its clinicopathological and prognostic associations in surgically resected cutaneous angiosarcoma.
Bi Y; Ge L; Ren X; Pang J; Zhao Y; Liang Z
Clin Transl Oncol; 2022 May; 24(5):941-949. PubMed ID: 35064455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
